{"result": {"id": "0c0c2f34-9b31-4a23-ab24-b08a46b00a8a", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "I notice the original text is primarily about pharmaceutical drug combinations and dosages, which don't clearly fit into the requested entity types (organization, person, geo, event). The text doesn't contain any proper names of organizations, people, geographical locations, or events that would qualify as entities under these categories.\n\nSince no valid entities matching the requested types (organization, person, geo, event) were found in the text, I'll confirm there are no additional entities to extract under these categories.\n\n<|COMPLETE|>", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1751558685, "model": "deepseek-chat", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_8802369eaa_prod0623_fp8_kvcache", "usage": {"completion_tokens": 105, "prompt_tokens": 4404, "total_tokens": 4509, "completion_tokens_details": null, "prompt_tokens_details": {"audio_tokens": null, "cached_tokens": 4352}, "prompt_cache_hit_tokens": 4352, "prompt_cache_miss_tokens": 52}}, "input": {"messages": [{"content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: �\n奥美沙坦 20mg/氢氯噻嗪 12. 5 mg\t\n1~2\t\n1\t偶见血管神经性水肿 ,血钾异常\n坎地沙坦酯/氢氯噻嗪\t\t\t偶见血管神经性水肿 ,血钾异常\n坎地沙坦酯 16mg/氢氯噻嗪 12. 5 mg\t1\t1\t\n卡托普利/氢氯噻嗪\n卡托普利 10mg/氢氯噻嗪 6 mg\t\n1~2\t\n1~2\t咳嗽 ,偶见血管神经性水肿 ,血钾异常\n赖诺普利/氢氯噻嗪\t\t\t咳嗽 ,偶见血管神经性水肿 ,血钾异常\n赖诺普利 10mg/氢氯噻嗪 12. 5 mg\t1\t1\t\n依那普利/氢氯噻嗪\n依那普利 5 mg/氢氯噻嗪 12. 5 mg\t\n1\t\n1\t咳嗽 ,偶见血管神经性水肿 ,血钾异常\n贝那普利/氢氯噻嗪\t\t\t咳嗽 ,偶见血管神经性水肿 ,血钾异常\n贝那普利 10mg/氢氯噻嗪 12. 5 mg\t1\t1\t\n培哚普利/吲达帕胺\n培哚普利 4 mg/吲达帕胺 1. 25mg\t\n1\t\n1\t咳嗽 ,偶见血管神经性水肿 ,血钾异常\n培哚普利/氨氯地平\t\t\t头晕 ,头痛 , 咳嗽\n精氨酸培哚普利 10mg/苯磺酸氨氯地平 5 mg\t1\t1\t\n精氨酸培哚普利 5 mg/苯磺酸氨氯地平 10mg\t1\t1\t\n精氨酸培哚普利 10mg/苯磺酸氨氯地平 10mg\t1\t1\t\n缬沙坦/氨氯地平\n缬沙坦 80mg/氨氯地平 5 mg   缬沙坦 160mg/氨氯地平 5 mg\t\n1~2 1~2\t\n1\n1\t头痛 ,踝部水肿 ,偶见血管神经性水肿\n替米沙坦/氨氯地平\t\t\t头痛 ,踝部水肿 ,偶见血管神经性水肿\n替米沙坦 80mg/氨氯地平 5 mg\t1\t1\t\n氨氯地平/氯沙坦\n氨氯地平 5 mg/氯沙坦钾 50mg   氨氯地平 5 mg/氯沙坦钾 100mg\t\n1\n1\t\n1\n1\t头痛 ,踝部水肿 ,偶见血管神经性水肿\n氨氯地平/贝那普利\t\t\t头痛 ,踝部水肿 ,偶见血管神经性水肿\n氨氯地平 2. 5 mg/贝那普利 10mg\t1~4\t1\t\n氨氯地平 5 mg/贝那普利 10mg\t1~2\t1\t\n阿利沙坦酯/氨氯地平\n阿利沙坦酯 240mg/氨氯地平 5 mg\t\n1\t\n1\t头痛 ,头晕\n氨氯地平/比索洛尔\t\t\t头痛 ,踝部水肿 ,支气管痉挛 ,心动过缓\n富马酸比索洛尔 5 mg/苯磺酸氨氯地平 5 mg\t1\t1\t\n尼群地平/阿替洛尔\n尼群地平 10mg/阿替洛尔 20mg �\n######################\nOutput:", "role": "user"}, {"role": "assistant", "content": "(\"entity\"<|>奥美沙坦 20mg/氢氯噻嗪 12.5 mg<|>organization<|>A combination medication containing Olmesartan and Hydrochlorothiazide, used for treating hypertension, with potential side effects like angioedema and abnormal potassium levels)\n##\n(\"entity\"<|>坎地沙坦酯/氢氯噻嗪<|>organization<|>A combination medication containing Candesartan and Hydrochlorothiazide, used for treating hypertension, with potential side effects like angioedema and abnormal potassium levels)\n##\n(\"entity\"<|>坎地沙坦酯 16mg/氢氯噻嗪 12.5 mg<|>organization<|>A specific dosage combination of Candesartan and Hydrochlorothiazide for hypertension treatment)\n##\n(\"entity\"<|>卡托普利/氢氯噻嗪<|>organization<|>A combination medication containing Captopril and Hydrochlorothiazide, used for treating hypertension, with potential side effects like cough, angioedema, and abnormal potassium levels)\n##\n(\"entity\"<|>卡托普利 10mg/氢氯噻嗪 6 mg<|>organization<|>A specific dosage combination of Captopril and Hydrochlorothiazide for hypertension treatment)\n##\n(\"entity\"<|>赖诺普利/氢氯噻嗪<|>organization<|>A combination medication containing Lisinopril and Hydrochlorothiazide, used for treating hypertension, with potential side effects like cough, angioedema, and abnormal potassium levels)\n##\n(\"entity\"<|>赖诺普利 10mg/氢氯噻嗪 12.5 mg<|>organization<|>A specific dosage combination of Lisinopril and Hydrochlorothiazide for hypertension treatment)\n##\n(\"entity\"<|>依那普利/氢氯噻嗪<|>organization<|>A combination medication containing Enalapril and Hydrochlorothiazide, used for treating hypertension, with potential side effects like cough, angioedema, and abnormal potassium levels)\n##\n(\"entity\"<|>依那普利 5 mg/氢氯噻嗪 12.5 mg<|>organization<|>A specific dosage combination of Enalapril and Hydrochlorothiazide for hypertension treatment)\n##\n(\"entity\"<|>贝那普利/氢氯噻嗪<|>organization<|>A combination medication containing Benazepril and Hydrochlorothiazide, used for treating hypertension, with potential side effects like cough, angioedema, and abnormal potassium levels)\n##\n(\"entity\"<|>贝那普利 10mg/氢氯噻嗪 12.5 mg<|>organization<|>A specific dosage combination of Benazepril and Hydrochlorothiazide for hypertension treatment)\n##\n(\"entity\"<|>培哚普利/吲达帕胺<|>organization<|>A combination medication containing Perindopril and Indapamide, used for treating hypertension, with potential side effects like cough, angioedema, and abnormal potassium levels)\n##\n(\"entity\"<|>培哚普利 4 mg/吲达帕胺 1.25 mg<|>organization<|>A specific dosage combination of Perindopril and Indapamide for hypertension treatment)\n##\n(\"entity\"<|>培哚普利/氨氯地平<|>organization<|>A combination medication containing Perindopril and Amlodipine, used for treating hypertension, with potential side effects like dizziness, headache, and cough)\n##\n(\"entity\"<|>精氨酸培哚普利 10mg/苯磺酸氨氯地平 5 mg<|>organization<|>A specific dosage combination of Arginine Perindopril and Amlodipine Besylate for hypertension treatment)\n##\n(\"entity\"<|>精氨酸培哚普利 5 mg/苯磺酸氨氯地平 10 mg<|>organization<|>A specific dosage combination of Arginine Perindopril and Amlodipine Besylate for hypertension treatment)\n##\n(\"entity\"<|>精氨酸培哚普利 10mg/苯磺酸氨氯地平 10 mg<|>organization<|>A specific dosage combination of Arginine Perindopril and Amlodipine Besylate for hypertension treatment)\n##\n(\"entity\"<|>缬沙坦/氨氯地平<|>organization<|>A combination medication containing Valsartan and Amlodipine, used for treating hypertension, with potential side effects like headache, ankle edema, and angioedema)\n##\n(\"entity\"<|>缬沙坦 80mg/氨氯地平 5 mg<|>organization<|>A specific dosage combination of Valsartan and Amlodipine for hypertension treatment)\n##\n(\"entity\"<|>缬沙坦 160mg/氨氯地平 5 mg<|>organization<|>A specific dosage combination of Valsartan and Amlodipine for hypertension treatment)\n##\n(\"entity\"<|>替米沙坦/氨氯地平<|>organization<|>A combination medication containing Telmisartan and Amlodipine, used for treating hypertension, with potential side effects like headache, ankle edema, and angioedema)\n##\n(\"entity\"<|>替米沙坦 80mg/氨氯地平 5 mg<|>organization<|>A specific dosage combination of Telmisartan and Amlodipine for hypertension treatment)\n##\n(\"entity\"<|>氨氯地平/氯沙坦<|>organization<|>A combination medication containing Amlodipine and Losartan, used for treating hypertension, with potential side effects like headache, ankle edema, and angioedema)\n##\n(\"entity\"<|>氨氯地平 5 mg/氯沙坦钾 50 mg<|>organization<|>A specific dosage combination of Amlodipine and Losartan Potassium for hypertension treatment)\n##\n(\"entity\"<|>氨氯地平 5 mg/氯沙坦钾 100 mg<|>organization<|>A specific dosage combination of Amlodipine and Losartan Potassium for hypertension treatment)\n##\n(\"entity\"<|>氨氯地平/贝那普利<|>organization<|>A combination medication containing Amlodipine and Benazepril, used for treating hypertension, with potential side effects like headache, ankle edema, and angioedema)\n##\n(\"entity\"<|>氨氯地平 2.5 mg/贝那普利 10 mg<|>organization<|>A specific dosage combination of Amlodipine and Benazepril for hypertension treatment)\n##\n(\"entity\"<|>氨氯地平 5 mg/贝那普利 10 mg<|>organization<|>A specific dosage combination of Amlodipine and Benazepril for hypertension treatment)\n##\n(\"entity\"<|>阿利沙坦酯/氨氯地平<|>organization<|>A combination medication containing Allisartan Isoproxil and Amlodipine, used for treating hypertension, with potential side effects like headache and dizziness)\n##\n(\"entity\"<|>阿利沙坦酯 240mg/氨氯地平 5 mg<|>organization<|>A specific dosage combination of Allisartan Isoproxil and Amlodipine for hypertension treatment)\n##\n(\"entity\"<|>氨氯地平/比索洛尔<|>organization<|>A combination medication containing Amlodipine and Bisoprolol, used for treating hypertension, with potential side effects like headache, ankle edema, bronchospasm, and bradycardia)\n##\n(\"entity\"<|>富马酸比索洛尔 5 mg/苯磺酸氨氯地平 5 mg<|>organization<|>A specific dosage combination of Bisoprolol Fumarate and Amlodipine Besylate for hypertension treatment)\n##\n(\"entity\"<|>尼群地平/阿替洛尔<|>organization<|>A combination medication containing Nitrendipine and Atenolol, used for treating hypertension)\n##\n(\"entity\"<|>尼群地平 10mg/阿替洛尔 20 mg<|>organization<|>A specific dosage combination of Nitrendipine and Atenolol for hypertension treatment)\n<|COMPLETE|>"}, {"content": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "role": "user"}], "parameters": {"model": "deepseek-chat", "frequency_penalty": 0.0, "max_tokens": 4000, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}, "key": "chat_extract-continuation-0_34eae962d00a68310b29d87b981c77b0d4cb34f60bbf0e83b1cf5558d8917545_v2"}